openPR Logo
Press release

Global Vaccines Market and Projected to Reach US$ 50.42 Billion Grow at CAGR 6.7% to 2023

09-14-2018 11:40 AM CET | Health & Medicine

Press release from: RnRMarketResearch.com

The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%.

Key Companies Analysis: GlaxoSmithKline, plc (UK), Pfizer, Inc. (US), Merck & Co., Inc. (US), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), MedImmune, LLC (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (US), and Panacea Biotec (India).

Ask for Free Sample Papers of Vaccines Market with Top Trends and Company Profile at www.rnrmarketresearch.com/contacts/request-sample?rname=1... .

A vaccine is made from very small amounts of weak or dead germs that can cause diseases — for example, viruses, bacteria, or toxins. It prepares your body to fight the disease faster and more effectively so you won’t get sick.

Vaccines Market, By Technology
1 Introduction
2 Conjugate Vaccines
3 Inactivated and Subunit Vaccines
4 Live Attenuated Vaccines
5 Recombinant Vaccines
6 Toxoid Vaccines

Premium Insights
1 Overview of the Vaccines Market
2 Vaccines Market, By Type, 2018–2023
3 Vaccines Market, By End User, 2018 vs 2023 (USD Billion)
4 Geographic Analysis: Vaccines Market, By Technology
5 Vaccines Market, By Route of Administration, 2018 vs 2023 (USD Billion)
6 Geographical Snapshot of the Vaccines Market

The vaccines market is segmented intomonovalent vaccines and multivalent vaccines. The monovalent segment is expected to dominate this market with the largest share due to increasing investments by companies to develop new vaccines.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%; Tier 2 - 41%; Tier 3 - 23%.
• By Designation (Supply Side): C-level- 25%; D-level- 29%; Others- 46%.
• By Designation (Demand Side): General Physicians- 38%; Purchase Managers- 29%; Medical Researchers- 33%.
• By Region: North America-40%; Europe-20%;Asia-33%; RoW-7%.

Know more about “Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023” report at www.rnrmarketresearch.com/contacts/inquire-before-buying?... .
The report provides an overview of the vaccines market.It aims at estimating the market size and future growth potential of this market across different segments such as technology, type, disease indication, route of administration, end user,and region.

Target audience
1 Manufacturers and suppliers of vaccines
2 Research and development companies
3 Medical research laboratories
4 Academic medical centers and universities
5 Research and consulting firms
6 Venture capital firms

Click here for Discount @ www.rnrmarketresearch.com/contacts/discount?rname=110437 .

List of Tables
1 Incidence of Diseases
2 NIH Funding for Vaccine Research, 2013–2018 (USD Million)
3 Immunization Coverage, By Disease, 2015 vs 2016
4 Regulatory Authorities in Europe
5 Regulatory Authorities in Asia
6 Key Pipeline Vaccines
7 Estimated Investments in HIV Vaccines, By Investor (2015–2016)
8 Ebola Projects Funded By Ec (2014–2020)
9 Vaccines Market, By Technology, 2016–2023 (USD Million)
10 Cost of Meningococcal Conjugate Vaccines

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Vaccines Market and Projected to Reach US$ 50.42 Billion Grow at CAGR 6.7% to 2023 here

News-ID: 1239381 • Views: 1626

More Releases from RnRMarketResearch.com

Healthcare Business Intelligence Market Reaching to US$ 8.9 Billion Revenue to 2 …
The healthcare business intelligence market dominated by OLAP & visualization, performance management, and query & reporting. Report provides a picture of the global healthcare business intelligence market. Get Free Sample Papers of Healthcare Business Intelligence Market with 194 Pages and 12 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=175696 . Healthcare business intelligence market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% during
Cybersecurity Market Is Booming Worldwide | Global Key Players like IBM, Check P …
RnRMarketResearch always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Cybersecurity Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample Report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=165017 . Top Companies profiled in the Cybersecurity Market include
In-flight Entertainment & Connectivity Market worth 7.65 Billion USD till 2023 | …
RnRMarketResearch always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global In-flight Entertainment & Connectivity Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample Report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=413629 . The In-Flight Entertainment & Connectivity
17.4% Growth Rate for TV Analytics Market by 2023 | Top Technologies, Overview, …
RnRMarketResearch always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global TV Analytics Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample Report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=1771705 . Top Companies profiled in the TV Analytics

All 5 Releases


More Releases for Vaccine

Tetanus Toxoid Vaccine Market
The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. Market Highlights: Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the
Vaccine Market Demand is Increasing
U.S. Vaccine Market: Snapshot The overall vaccine industry has strengthened itself in terms of its growth rate, with a relatively higher growth rate than most other healthcare market segments. Vaccination has been an invaluable addition to better public health, and has helped millions of children, adults and animals from deadly diseases. The CDC stated in a report that diseases such as diphtheria, polio, and smallpox have been fully eliminated, while measles,
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s
Shingles Vaccine Market
The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases chicken pox. The virus can stay dormant for many years in the human body. Therefore, anyone who has had